Cystatin C and albuminuria as risk factors for development of CKD stage 3: The multi-ethnic study of atherosclerosis (MESA)

American Journal of Kidney Diseases

Volumn 57, Issue 6, 2011, Pages 832-840

  Shastri, Shani ^a   Katz, Ronit ^b   Shlipak, Michael G ^c   Kestenbaum, Bryan ^b   Peralta, Carmen A ^c   Kramer, Holly ^d   Jacobs Jr , David R ^e   De Boer, Ian H ^b   Cushman, Mary ^f   Siscovick, David ^b   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

Albuminuria; chronic kidney disease; cystatin C; risk factors

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBSERVATIONAL STUDY; POISSON DISTRIBUTION; PROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; CYSTATIN C; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79956339923     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.11.021     Document Type: Article

References (58)

1. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
2. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 1998 S16 S23
3. L.F. Fried, M.G. Shlipak, and C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 8 2003 1364 1372 (Pubitemid 36438998)
4. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
5. G. Manjunath, H. Tighiouart, and J. Coresh Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney Int 63 3 2003 1121 1129 (Pubitemid 36315592)
6. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 5 2003 1050 1065 (Pubitemid 37413751)
7. D.E. Weiner, H. Tighiouart, and M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 5 2004 1307 1315 (Pubitemid 38526012)
8. M. Kurella, G.M. Chertow, and L.F. Fried Chronic kidney disease and cognitive impairment in the elderly: the Health, Aging, and Body Composition Study J Am Soc Nephrol 16 7 2005 2127 2133 (Pubitemid 41716444)
9. S.L. Seliger, D.S. Siscovick, and C.O. Stehman-Breen Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study J Am Soc Nephrol 15 7 2004 1904 1911 (Pubitemid 38822071)
10. M.G. Shlipak, C. Stehman-Breen, and L.F. Fried The presence of frailty in elderly persons with chronic renal insufficiency Am J Kidney Dis 43 5 2004 861 867 (Pubitemid 38529624)
11. E.R. Wilhelm-Leen, Y.N. Hall, M.K. Tamura, and G.M. Chertow Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey Am J Med 122 7 2009 664 671 e2
12. F.Y. Chow, E.M. Briganti, P.G. Kerr, S.J. Chadban, P.Z. Zimmet, and R.C. Atkins Health-related quality of life in Australian adults with renal insufficiency: a population-based study Am J Kidney Dis 41 3 2003 596 604 (Pubitemid 36278377)
13. I. Gorodetskaya, S. Zenios, and C.E. McCulloch Health-related quality of life and estimates of utility in chronic kidney disease Kidney Int 68 6 2005 2801 2808 (Pubitemid 43251026)
14. C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, and D. Levy Predictors of new-onset kidney disease in a community-based population JAMA 291 7 2004 844 850 (Pubitemid 38543772)
15. M.W. Taal, and B.M. Brenner Renal risk scores: progress and prospects Kidney Int 73 11 2008 1216 1219 (Pubitemid 351693152)
16. R.P. Gelber, T. Kurth, and A.T. Kausz Association between body mass index and CKD in apparently healthy men Am J Kidney Dis 46 5 2005 871 880 (Pubitemid 41505461)
17. E.F. Elsayed, M.J. Sarnak, and H. Tighiouart Waist-to-hip ratio, body mass index, and subsequent kidney disease and death Am J Kidney Dis 52 1 2008 29 38 (Pubitemid 351853273)
18. M. Kurella, J.C. Lo, and G.M. Chertow Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 7 2005 2134 2140 (Pubitemid 41716445)
19. C.E. Mogensen, W.F. Keane, and P.H. Bennett Prevention of diabetic renal disease with special reference to microalbuminuria Lancet 346 8982 1995 1080 1084
20. J.C. Verhave, R.T. Gansevoort, H.L. Hillege, S.J. Bakker, D. De Zeeuw, and P.E. de Jong An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population Kidney Int Suppl 92 2004 S18 S21
21. M.G. Shlipak, R. Katz, and M.J. Sarnak Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 4 2006 237 246 (Pubitemid 46768607)
22. J. Segura, C. Campo, and P. Gil Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients J Am Soc Nephrol 15 6 2004 1616 1622 (Pubitemid 38679687)
23. E. Coll, A. Botey, and L. Alvarez Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment Am J Kidney Dis 36 1 2000 29 34 (Pubitemid 30432560)
24. D.J. Newman, H. Thakkar, and R.G. Edwards Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine Kidney Int 47 1 1995 312 318
25. P. Fioretto, M. Mauer, and E. Brocco Patterns of renal injury in NIDDM patients with microalbuminuria Diabetologia 39 12 1996 1569 1576 (Pubitemid 26397369)
26. C.E. Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 6 1984 356 360 (Pubitemid 14179541)
27. C.E. Mogensen, C.K. Christensen, and E. Vittinghus The stages in diabetic renal disease With emphasis on the stage of incipient diabetic nephropathy Diabetes 32 suppl 2 1983 64 78 (Pubitemid 13099685)
28. G.C. Viberti, R.D. Hill, R.J. Jarrett, A. Argyropoulos, U. Mahmud, and H. Keen Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1 8287 1982 1430 1432 (Pubitemid 12123979)
29. D.E. Bild, D.A. Bluemke, and G.L. Burke Multi-Ethnic Study of Atherosclerosis: objectives and design Am J Epidemiol 156 9 2002 871 881 (Pubitemid 35215769)
30. J.H. Warram, G. Gearin, L. Laffel, and A.S. Krolewski Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio J Am Soc Nephrol 7 6 1996 930 937 (Pubitemid 27465988)
31. H. Kramer, W. Palmas, and B. Kestenbaum Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ethnic Study of Atherosclerosis Clin J Am Soc Nephrol 3 5 2008 1391 1397
32. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate Ann Intern Med 145 4 2006 247 254 (Pubitemid 46768608)
33. M.G. Shlipak, M.J. Sarnak, and R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060 (Pubitemid 40664306)
34. M.G. Shlipak, C.L. Wassel Fyr, and G.M. Chertow Cystatin C and mortality risk in the elderly: the Health, Aging, and Body Composition Study J Am Soc Nephrol 17 1 2006 254 261
35. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
36. D. Fliser, and E. Ritz Serum cystatin C concentration as a marker of renal dysfunction in the elderly Am J Kidney Dis 37 1 2001 79 83 (Pubitemid 32055022)
37. A.D. Rule, E.J. Bergstralh, J.M. Slezak, J. Bergert, and T.S. Larson Glomerular filtration rate estimated by cystatin C among different clinical presentations Kidney Int 69 2 2006 399 405 (Pubitemid 43323094)
38. E.D. Poggio, X. Wang, T. Greene, F. Van Lente, and P.M. Hall Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease J Am Soc Nephrol 16 2 2005 459 466 (Pubitemid 41725142)
39. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney functionmeasured and estimated glomerular filtration rate N Engl J Med 354 23 2006 2473 2483 (Pubitemid 43855050)
40. E.L. Knight, J.C. Verhave, and D. Spiegelman Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int 65 4 2004 1416 1421 (Pubitemid 38406982)
41. L.A. Stevens, C.H. Schmid, and T. Greene Factors other than glomerular filtration rate affect serum cystatin C levels Kidney Int 75 6 2009 652 660
42. S.I. Hallan, E. Ritz, S. Lydersen, S. Romundstad, K. Kvenild, and S.R. Orth Combining GFR and albuminuria to classify CKD improves prediction of ESRD J Am Soc Nephrol 20 5 2009 1069 1077
43. B.R. Hemmelgarn, B.J. Manns, and A. Lloyd Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 5 2010 423 429
44. K. Iseki, Y. Ikemiya, C. Iseki, and S. Takishita Proteinuria and the risk of developing end-stage renal disease Kidney Int 63 4 2003 1468 1474 (Pubitemid 36350012)
45. B.A. Perkins, L.H. Ficociello, and B.E. Ostrander Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes J Am Soc Nephrol 18 4 2007 1353 1361 (Pubitemid 46536923)
46. K.E. Paisley, M. Beaman, J.E. Tooke, V. Mohamed-Ali, G.D. Lowe, and A.C. Shore Endothelial dysfunction and inflammation in asymptomatic proteinuria Kidney Int 63 2 2003 624 633 (Pubitemid 36126808)
47. E.F. Elsayed, H. Tighiouart, and J. Griffith Cardiovascular disease and subsequent kidney disease Arch Intern Med 167 11 2007 1130 1136 (Pubitemid 46919815)
48. D. Fliser, F. Kronenberg, and J.T. Kielstein Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study J Am Soc Nephrol 16 8 2005 2456 2461 (Pubitemid 41725064)
49. Y. Matsumoto, S. Ueda, and S. Yamagishi Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease J Am Soc Nephrol 18 5 2007 1525 1533 (Pubitemid 46717519)
50. C.A. Peralta, R. Katz, and M. Madero The differential association of kidney dysfunction with small and large arterial elasticity: the Multiethnic Study of Atherosclerosis Am J Epidemiol 169 6 2009 740 748
51. S. Ueda, S. Yamagishi, Y. Matsumoto, K. Fukami, and S. Okuda Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease Clin Exp Nephrol 11 2 2007 115 121 (Pubitemid 47012517)
52. C.E. Mogensen Prediction of clinical diabetic nephropathy in IDDM patients Alternatives to microalbuminuria? Diabetes 39 7 1990 761 767 (Pubitemid 20211422)
53. R.G. Nelson, P.H. Bennett, and G.J. Beck Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus Diabetic Renal Disease Study Group N Engl J Med 335 22 1996 1636 1642 (Pubitemid 26392728)
54. S.J. Pinto-Sietsma, W.M. Janssen, H.L. Hillege, G. Navis, D. De Zeeuw, and P.E. De Jong Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population J Am Soc Nephrol 11 10 2000 1882 1888
55. P.E. de Jong, and B.M. Brenner From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria Kidney Int 66 6 2004 2109 2118 (Pubitemid 41115274)
56. J.F. Mann, H.C. Gerstein, and Q.L. Yi Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study J Am Soc Nephrol 14 3 2003 641 647 (Pubitemid 36246007)
57. J. Arnlov, J.C. Evans, and J.B. Meigs Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study Circulation 112 7 2005 969 975 (Pubitemid 41170264)
58. M.R. Weir Microalbuminuria and cardiovascular disease Clin J Am Soc Nephrol 2 3 2007 581 590